Cyclacel highlighted a study originating from Kuala Lumpur, Malaysia.
2 reports, 1 independent
Updated Aug 5
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cyclacel highlighted a study originating from Kuala Lumpur, Malaysia.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Research was conducted in Sarawak.
- CytoMed Therapeutics Limited is targeting markets in Malaysia and Singapore.
- Selangor leverages its status as a key industrial destination in Malaysia.
- A small-cap consumer staples company, Agape ATP Corporation, supplies health products and services in Malaysia, alongside Nu Skin Enterprises.
- A company operating in the Malaysian oil and gas industry is now under anti-corruption investigation by Malaysian authorities.
Coverage
Newest first; wire copies grouped- GlobeNewswireCYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB - Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor wit
- GlobeNewswireCYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY Kuala Lumpur, Malaysia, July 16, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or